Lantheus inks purchasing deal with MDS Nordion for rare isotope

July 8, 2010 by MassDevice staff

Lantheus Medical Imaging Inc. arranges a new manufacturing and supply deal for molybdenum-99, the main ingredient for its imaging isotope generators.

Lantheus logo

Lantheus Medical Imaging Inc. sealed a new purchasing deal with Ottawa-based MDS Nordion for a rare imaging isotope, molybdenum-99.

The Billerica, Mass.-based medical imaging company will begin receiving a weekly supply of Mo-99 when the National Research Universal reactor in Chalk River, Ontario, goes back online, expected the end of July. The contract is good through July 2011.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.